Compounds > fingolimod hydrochloride
Page last updated: 2024-09-02

fingolimod hydrochloride and temozolomide

fingolimod hydrochloride has been researched along with temozolomide in 3 studies

Compound Research Comparison

Studies
(fingolimod hydrochloride)		Trials
(fingolimod hydrochloride)		Recent Studies (post-2010)
(fingolimod hydrochloride)		Studies
(temozolomide)		Trials
(temozolomide)		Recent Studies (post-2010) (temozolomide)
2,7711572,0626,0148264,331

Research

Studies (3)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's2 (66.67)24.3611
2020's1 (33.33)2.80

Authors

AuthorsStudies
Estrada-Bernal, A; Palanichamy, K; Ray Chaudhury, A; Van Brocklyn, JR1
Wang, H; Zhang, L1
Al Barim, B; Di Fazio, P; Kolodziej, MA; Nagl, J; Schwarm, FP; Stein, M; Uhl, E; Uhle, F; Weigand, MA1

Other Studies

3 other study(ies) available for fingolimod hydrochloride and temozolomide

ArticleYear
Induction of brain tumor stem cell apoptosis by FTY720: a potential therapeutic agent for glioblastoma.
    Neuro-oncology, 2012, Volume: 14, Issue:4

    Topics: Animals; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Apoptosis; Apoptosis Regulatory Proteins; Bcl-2-Like Protein 11; Brain Neoplasms; Dacarbazine; Extracellular Signal-Regulated MAP Kinases; Fingolimod Hydrochloride; Glioblastoma; Humans; Induction Chemotherapy; Membrane Proteins; Mice; Mice, Nude; Neoplastic Stem Cells; Propylene Glycols; Proto-Oncogene Proteins; Receptors, Lysosphingolipid; Sphingosine; Temozolomide; Tumor Cells, Cultured; Xenograft Model Antitumor Assays

2012
FTY720 inhibits the Nrf2/ARE pathway in human glioblastoma cell lines and sensitizes glioblastoma cells to temozolomide.
    Pharmacological reports : PR, 2017, Volume: 69, Issue:6

    Topics: Antineoplastic Agents, Alkylating; Antioxidant Response Elements; Apoptosis; Autophagy; Brain Neoplasms; Cell Line, Tumor; Cell Survival; Dacarbazine; Drug Resistance, Neoplasm; Fingolimod Hydrochloride; Gene Knockdown Techniques; Glioblastoma; Heme Oxygenase-1; Humans; NF-E2-Related Factor 2; RNA, Messenger; RNA, Small Interfering; Temozolomide

2017
Sphingosine‑1‑phosphate analogue FTY720 exhibits a potent anti‑proliferative effect on glioblastoma cells.
    International journal of oncology, 2020, Volume: 57, Issue:4

    Topics: Antineoplastic Agents, Alkylating; Apoptosis; Brain Neoplasms; Cell Cycle; Cell Line, Tumor; Cell Proliferation; Fingolimod Hydrochloride; Glioblastoma; Humans; rho-Associated Kinases; Signal Transduction; Sphingosine 1 Phosphate Receptor Modulators; Temozolomide

2020